International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study.

By A. Buist, M. McBurnie, W. Vollmer, Suzanne E. Gillespie, P. Burney, David M. Mannino, Ana M B Menezes, S. Sullivan, Todd A. Lee, K. Weiss and 4 more. The Lancet, 2007

2,331 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Sociology and Political Science

View Paper: https://www.semanticscholar.org/paper/9d760abc9ee80690af520ad01562ba221e92ef0a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. D. Parums
2. P. Calverley
3. Jorgen Vestbo
4. Alvar Agusti
5. W. Macnee
6. Bartolome Celli
7. David M. Mannino
8. P. Barnes

In Sociology and Political Science

1. Jorgen Vestbo
2. D. Postma
3. P. Calverley
4. D. Parums

Citations in the corpus

• Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype (2012, background): “It affects around 10% of the adult population [4], and it is predicted that it will be the third cause of death and disability in the world by the year 2020 [5].”
• An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. (2010, methodology): “Further evidence of the role of other risk factors is the occurrence of COPD among neversmokers, with prevalence estimates ranging from approximately 3 to 15% in various populations using different methods (31, 36).”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Программа по оценке ущерба от ХОБЛ включа ла исследования в различных частях света [13], в ре зультате были выявлены значительно более тяжелые, чем были описаны ранее, формы заболевания и сущест венная распространенность ХОБЛ (3–11%) среди неку рящих.”